Evidence map›Paper›PMID 40550823›Full record

ArticleCommunications chemistry2025

Developing a new cleavable crosslinker reagent for in-cell crosslinking.

Fränze Müller, Bogdan R Brutiu, Iakovos Saridakis, Thomas Leischner, Micha J Birklbauer, Manuel Matzinger, Mathias Madalinski, Thomas Lendl, Saad Shaaban, Viktoria Dorfer and 2 more

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fränze Müller *Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria.ORCID http://orcid.org/0000-0003-3764-3547
Bogdan R Brutiu *Institute of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0003-3952-8120
Iakovos SaridakisInstitute of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090, Vienna, Austria.
Thomas LeischnerInstitute of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090, Vienna, Austria.
Micha J BirklbauerBioinformatics Research Group, University of Applied Sciences Upper Austria, Softwarepark 11, 4232, Hagenberg, Upper Austria, Austria.ORCID http://orcid.org/0009-0005-1051-179X
Manuel MatzingerInstitute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria.ORCID http://orcid.org/0000-0002-9765-7951
Mathias MadalinskiInstitute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria.
Thomas LendlInstitute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria.
Saad ShaabanInstitute of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090, Vienna, Austria.
Viktoria DorferBioinformatics Research Group, University of Applied Sciences Upper Austria, Softwarepark 11, 4232, Hagenberg, Upper Austria, Austria. viktoria.dorfer@fh-hagenberg.at.ORCID http://orcid.org/0000-0002-5332-5701
Nuno MaulideInstitute of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090, Vienna, Austria. nuno.maulide@univie.ac.at.ORCID http://orcid.org/0000-0003-3643-0718
Karl MechtlerInstitute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria. karl.mechtler@imp.ac.at.ORCID http://orcid.org/0000-0002-3392-9946

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crosslinking mass spectrometry (XL-MS) is a powerful technology that recently emerged as an essential complementary tool for elucidating protein structures and mapping interactions within a protein network. Crosslinkers which are amenable to post-linking backbone cleavage simplify peptide identification, aid in 3D structure determination and enable system-wide studies of protein-protein interactions (PPIs) in cellular environments. However, state-of-the-art cleavable linkers are fraught with practical limitations, including extensive evaluation of fragmentation energies and fragmentation behavior of the crosslinker backbone. We herein introduce DiSPASO (bis(2,5-dioxopyrrolidin-1-yl) 3,3'-((5-ethynyl-1,3-phenylene)bis(methylenesulfinyl))dipropanoate) as a lysine-selective, MS-cleavable crosslinker with an alkyne handle for affinity enrichment. DiSPASO was designed and developed for efficient cell membrane permeability and crosslinking while securing low cellular perturbation. We tested DiSPASO employing three different copper-based enrichment strategies using model systems with increasing complexity (Cas9-Halo, purified ribosomes, live cells). Fluorescence microscopy in-cell crosslinking experiments revealed a rapid uptake of DiSPASO into HEK 293 cells within 5 minutes. While DiSPASO represents progress in cellular PPI analysis, its limitations and low crosslinking yield in cellular environments require careful optimisation of the crosslinker design, highlighting the complexity of developing effective XL-MS tools and the importance of continuous innovation in accurately mapping PPI networks within dynamic cellular environments.

Identifiers

PMID40550823
PMCPMC12185727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.